Other Consolidated Financial Statement Detail (Tables)

9 Months Ended

Sep. 30, 2011

Business and Collaborations [Abstract]

Other income (expense), net

	For the Three Months						For the Nine Months
	Ended September 30,						Ended September 30,
(In millions)	2011			2010			2011			2010
Interest income	$	5.3		$	3.1		$	13.3		$	18.6
Interest expense		(7.9	)		(9.3	)		(25.5	)		(26.6	)
Impairments of investments		(0.8	)		(2.8	)		(7.6	)		(19.8	)
Foreign exchange losses, net		(4.8	)		(3.5	)		(5.8	)		(3.2	)
Gain (loss) on sales of investments, net		(0.1	)		4.8			15.4			16.1
Other, net		0.6			0.8			0.7			0.6
Total other income (expense), net	$	(7.7	)	$	(6.9	)	$	(9.5	)	$	(14.3	)

Other current assets

	As of		As of
	September 30,		December 31,
(In millions)	2011		2010
Deferred tax assets	$	38.2	$	112.2
Prepaid taxes		29.4		31.4
Receivable from collaborations		12.9		7.3
Interest receivable		7.6		4.9
Derivative assets		18.9		1.3
Other prepaid expenses		60.8		47.9
Other		26.4		10.8
Total other current assets	$	194.2	$	215.8

Accrued Expenses and Other

	As of		As of
	September 30,		December 31,
(In millions)	2011		2010
Employee compensation and benefits	$	144.3	$	159.7
Revenue-related rebates		119.2		105.3
Restructuring reserve		2.6		66.4
Royalties and licensing fees		42.9		45.1
Deferred revenue		59.9		41.3
Collaboration expenses		51.7		31.6
Clinical development expenses		42.6		24.4
Interest payable		5.4		21.6
Construction in progress accrual		16.3		16.4
Current portion of contingent consideration		9.0		11.9
Derivative liabilities		2.0		12.2
Other		178.8		130.0
Total accrued expenses and other	$	674.7	$	665.9